Office Of Regulatory Affairs Faces Training Challenges
This article was originally published in The Tan Sheet
Executive Summary
Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers